| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/03/2013 | CN103012598A OGP-rhLeptin fusion protein for treating osteoporosis and obesity and nucleic acid encoding same |
| 04/03/2013 | CN103012597A OGP-CTx fusion protein for treating osteoporosis and relieving pain and nucleic acid encoding same |
| 04/03/2013 | CN103012596A Endomorphin-derived peptide with blood-brain barrier permeability as well as synthesis and application of endomorphin-derived peptide |
| 04/03/2013 | CN103012595A Stable NT-probBNP calibrator and application thereof |
| 04/03/2013 | CN103012589A Human anti-vascular endothelial cell growth factor antibody and application thereof |
| 04/03/2013 | CN102357246B EGFR and HER2 combined polypeptide epitope vaccine |
| 04/03/2013 | CN102127148B Polypeptide in cluster-of-differentiation part on surface of vascular endothelial cell and use thereof |
| 04/03/2013 | CN102120774B Synthesis method of artificial antigen suitable for erythrosine pigment |
| 04/02/2013 | US8410061 Variants of hedgehog protein that contain N-terminal modifications are described that can block hedgehog function; thus allowing these variants to serve as functional antagonists. These peptides have a primary amino acid sequence |
| 04/02/2013 | US8409826 TAT-utrophin as a protein therapy for dystrophinopathies |
| 04/02/2013 | CA2453062C Group b streptococcus bvh-a5 antigens and corresponding dna fragments |
| 04/02/2013 | CA2449412C Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 04/02/2013 | CA2420652C Vertebrate intestinal protein which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/28/2013 | WO2013043071A1 Modified albumin-binding domains and uses thereof to improve pharmacokinetics |
| 03/28/2013 | WO2013041966A1 Vaccibodies targeted to cross-presenting dendritic cells |
| 03/28/2013 | WO2012169822A3 Fusion protein for suppressing cancer cell growth and suppressing vasculogenesis, and anticancer composition comprising same |
| 03/28/2013 | WO2012165927A3 Secretory fusion protein for target tracking |
| 03/28/2013 | US20130079500 Fusion proteins for treating metabolic disorders |
| 03/28/2013 | US20130079493 Method for prepairing peptide inhibitors of a lipid-activated enzyme and peptides produced by same |
| 03/28/2013 | US20130079280 Fibronectin type iii domain-based multimeric scaffolds |
| 03/28/2013 | US20130079277 Therapeutic agents comprising elastin-like peptides |
| 03/28/2013 | US20130078188 Activatable cell penetrating peptides with quenched fluorophores |
| 03/28/2013 | CA2849822A1 Novel influenza hemagglutinin protein-based vaccines |
| 03/28/2013 | CA2849705A1 Modified albumin-binding domains and uses thereof to improve pharmacokinetics |
| 03/28/2013 | CA2849434A1 Influenza virus vaccines and uses thereof |
| 03/28/2013 | CA2849374A1 Vaccibodies targeted to cross-presenting dendritic cells |
| 03/27/2013 | EP2573122A2 Screening of abundantly secreted proteins and their use as fusion partners for the production of recombinant proteins |
| 03/27/2013 | EP2573112A1 Modulation of sirpa - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 03/27/2013 | EP2573103A1 Peptide domains that bind small molecules of industrial significance |
| 03/27/2013 | EP2573102A1 Peptide domains that bind small molecules of industrial significance |
| 03/27/2013 | EP2572726A1 Compositions comprising pneumococcal antigens |
| 03/27/2013 | EP2571990A2 Universal dengue virus sequences and methods of use |
| 03/27/2013 | EP2284195A9 Fusion proteins useful for detecting analytes |
| 03/27/2013 | CN103003300A Peptide conjugates of GLP-1 receptor agonists and gastrin and their use |
| 03/27/2013 | CN102994547A Recombinant human erythropoietin-CTP fusion protein production process and application |
| 03/27/2013 | CN102993314A Anti-tumor fusion protein, as well as preparation method and application thereof |
| 03/27/2013 | CN102993313A GM-CSF-TAT-CEA recombinant protein, method and application thereof |
| 03/27/2013 | CN102993312A GM-CSF-HER2 recombinant protein, method and application thereof |
| 03/27/2013 | CN102993311A Infusion protein of IDB (Infectious Bursal Disease) virus VP2 protein and LTB (Leukotrienes B) and application thereof |
| 03/27/2013 | CN102993310A Fusion protein of IBD (Infectious Bursal Disease) VP2 and IL (Interleukin)-2 and application thereof |
| 03/27/2013 | CN102993309A Human auxin fusion protein TAT-hGH as well as preparation method and application thereof |
| 03/27/2013 | CN102993308A Methicillin-resistant staphylococcus aureus (MRSA) vaccine recombinant protein antigen HI2 and preparation method and application thereof |
| 03/27/2013 | CN102993305A Humanized anti-human epidemic growth factor receptor (EGFR) antibody as well as encoding gene and application thereof |
| 03/27/2013 | CN102993303A Anti-interferon- alpha antibodies |
| 03/27/2013 | CN102993281A Insecticidal protein and coding gene and application thereof |
| 03/27/2013 | CN102993280A Insecticidal protein and coding gene and application thereof |
| 03/27/2013 | CN102321158B Polypeptide for preventing cell DNA synthesis and inhibiting cell proliferation and application |
| 03/27/2013 | CN102276731B High-motion-activity polypeptide capable of inhibiting cocaine induction and application thereof |
| 03/27/2013 | CN102199217B Hepatitis B virus multi-epitope fusion protein and preparation method and application thereof |
| 03/27/2013 | CN101528777B Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 03/27/2013 | CN101365715B Matrix metalloproteinase 11 vaccine |
| 03/27/2013 | CN101287748B Compositions and methods for fusion protein separation |
| 03/26/2013 | US8404814 Anti-EDB antibody-targeted IL-10 cytokine for therapy of rheumatoid arthritis |
| 03/26/2013 | CA2580796C Modified fc molecules having peptides inserted in internal loop regions |
| 03/21/2013 | WO2013040309A2 Wnt compositions and therapeutic uses of such compositions |
| 03/21/2013 | WO2013037090A1 Fusion protein comprising circularly permuted form of trail/apo2l, coding gene and use thereof |
| 03/21/2013 | US20130074199 Compositions and Methods for Brown Fat Induction and Activity Using FNDC5 |
| 03/21/2013 | US20130072660 Identification and use of novopeptides for the treatment of cancer |
| 03/21/2013 | US20130072437 Neuregulin isoforms,neuregulin polypeptides and uses thereof |
| 03/21/2013 | US20130072432 Ptd-uqcrb fusion polypeptide, and pharmaceutical composition for preventing and treating ischemic diseases, containing same |
| 03/21/2013 | US20130071419 Universal dengue virus sequences and methods of use |
| 03/21/2013 | US20130071413 Targeted immune conjugates |
| 03/21/2013 | US20130071375 Compositions and methods for treating inflammation |
| 03/21/2013 | US20130071320 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 03/21/2013 | CA2848841A1 Wnt compositions and therapeutic uses of such compositions |
| 03/21/2013 | CA2848410A1 Rna engineered t cells for the treatment of cancer |
| 03/21/2013 | CA2848403A1 Hyr1-derived compositions and methods of treatment using same |
| 03/21/2013 | CA2848204A1 Glucagon-like peptide-2 compositions and methods of making and using same |
| 03/20/2013 | EP2570425A2 Deletions in domain II of Pseudomonas exotoxin A that reduce non-specific toxicity |
| 03/20/2013 | EP2569332A1 Improved complement receptor 2 (cr2) targeting groups |
| 03/20/2013 | EP2569330A2 Chlorotoxin variants, conjugates, and methods for their use |
| 03/20/2013 | CN1541107B Growth factor complex |
| 03/20/2013 | CN102985109A Homodimeric protein constructs |
| 03/20/2013 | CN102977215A Caspase-1 inhibitor targeting liver and application thereof |
| 03/20/2013 | CN102977214A Recombinant protein HF2 used for methicillin-resistant staphylococcus aureus (MRSA) vaccine, and preparation method and application thereof |
| 03/20/2013 | CN102604993B Immunologic adjuvant-Helicobacter pylori antigen fused protein oral vaccine and preparation method thereof |
| 03/20/2013 | CN102321180B Polypeptide fragment composition and application in preparation of porcine reproductive and respiratory syndrome vaccine thereof |
| 03/20/2013 | CN102247603B Infusion protein with transdermal drug delivery property |
| 03/20/2013 | CN102174114B Whole blood INF-gamma specific antigen protein and preparation method and application thereof |
| 03/20/2013 | CN102101888B Novel polypeptide for resisting tumors caused by EB (Epstein-Barr) viruses, and application and preparation method thereof |
| 03/20/2013 | CN101906166B Streptococcus recombination subunit vaccine and preparation method |
| 03/19/2013 | US8398996 Staphylococcus aureus proteins and nucleic acids |
| 03/19/2013 | CA2705716C Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies |
| 03/14/2013 | WO2013036889A1 Retrograde transport peptide and use of same for delivery to central nervous system |
| 03/14/2013 | WO2012144778A9 Surface-active collagen barrier membrane to which a peptide is bound |
| 03/14/2013 | WO2012139086A3 Single chain antibodies for photosynthetic microorganisms and methods of use |
| 03/14/2013 | WO2012135177A3 Methods and compositions for cytomegalovirus il-10 protein |
| 03/14/2013 | WO2012115715A3 Compositions with enhanced immunogenicity and/or reduced reactogenicity and methods of use |
| 03/14/2013 | US20130066402 Engineered red-shifted channelrhodopsin variants |
| 03/14/2013 | US20130066052 Ucp4 |
| 03/14/2013 | US20130065840 Method and peptide for regulating cellular activity |
| 03/14/2013 | US20130065814 Inductive production of pluripotent stem cells using synthetic transcription factors |
| 03/14/2013 | US20130065299 Actriib-fc polynucleotides, polypeptides, and compositions |
| 03/14/2013 | US20130065278 Production of proteins and polypeptides |
| 03/14/2013 | US20130065267 Conjugates and methods for measuring chaperone-mediated autophagy |
| 03/14/2013 | US20130065235 Binding and functional assays that use the t1r3 receptor to screen for taste modulatory compounds |
| 03/14/2013 | US20130064895 Amphiphilic Peptides and Peptide Particles |
| 03/14/2013 | US20130064828 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease |
| 03/13/2013 | EP2407536A9 ADP-ribosyl transferase fusion variant proteins |
| 03/13/2013 | EP1392359B2 Specific binding proteins and uses thereof |